ACADIAN ASSET MANAGEMENT LLC

Position in DTIL — Precision Biosciences Inc

CIK 916542 Boston, MA

Position in DTIL

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$246,224

+$11,954 QoQ

Shares Held

44,768

-20.5% QoQ

Ownership

0.174%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 78 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. DTIL ranks #106 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$246,224	44,768	-20.5%	Shares	Defined	2026-05-13
2025-12-31	$234,270	56,315	-52.8%	Shares	Defined	2026-02-10
2025-09-30	$658,861	119,359	-47.2%	Shares	Defined	2025-11-13
2025-06-30	$948,935	225,937	-9.1%	Shares	Defined	2025-08-07
2025-03-31	$1,185,917	248,620	0.0%	Shares	Defined	2025-05-21
2024-12-31	$947,242	248,620	+65.5%	Shares	Defined	2025-02-11
2024-09-30	$1,345,612	150,180	+35.6%	Shares	Defined	2024-11-12
2024-06-30	$1,077,821	110,773	-3.1%	Shares	Defined	2024-08-06
2024-03-31	$1,549,528	114,272	—	Shares	Defined	2024-05-10
No filing history on record for this holder in this stock.